Symposium:
119. The Pediatric Microbiome
Friday, October 6, 2017: 8:30 AM-10:00 AM
Room: 16AB

Learning Objectives:

At the conclusion of this session, participants will be able to:

  • describe the role of the airway microbiome in cystic fibrosis
  • discuss the role of the microbiome in metabolic disorders
  • review the role of the microbiome in pediatric gastrointestinal disorders
  • explain how surgery influences infection processes in the human gut
  • review¬†what a pathobiome is and how can it influence sepsis progression
  • discuss the routes by which the microbiome can influence tumorigenesis

Target Audience: Academicians, Fellows, Healthcare workers, Hospital epidemiologists, Infection preventionists, Infectious diseases pediatricians, Infectious diseases physicians, Investigators, Lab personnel, Medical students and residents, Members-in-training, Microbiologists, Pharmacists, Researchers, Scientists

Tracks: Trainee, Pediatric ID, Adult ID, Global ID


Moderators:  Archana Chatterjee, MD, PhD, FIDSA, FPIDS, University of South Dakota Sanford School of Medicine/Sanford Children's Specialty Clinic and Vincent B. Young, MD, PhD, FIDSA, The University of Michigan

Presentations:
8:30 AM
938
9:20 AM
940
9:45 AM
Q&A

CME Credits: Maximum of 1.50 hours of AMA PRA Category 1 Credit™

ACPE Credits: ACPE 1.5 knowledge-based contact hours of pharmacy CE

ACPE Number: 0221-9999-17-271-L01-P

Disclosures:

A. Chatterjee, None

V. B. Young, None

See more of: Symposium

Findings in the abstracts are embargoed until 12:01 a.m. PDT, Wednesday Oct. 4th with the exception of research findings presented at the IDWeek press conferences.